T Quattrin

Summary

Affiliation: State University of New York at Buffalo
Country: USA

Publications

  1. ncbi request reprint Treatment outcomes of overweight children and parents in the medical home
    Teresa Quattrin
    Department of Pediatrics, University at Buffalo, Women and Children s Hospital, Buffalo, New York
    Pediatrics 134:290-7. 2014
  2. pmc Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study
    Lucy Mastrandrea
    Department of Pediatrics, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA
    Diabetes Care 32:1244-9. 2009
  3. pmc Efficacy of family-based weight control program for preschool children in primary care
    Teresa Quattrin
    Pediatric University at Buffalo, Buffalo, New York, USA
    Pediatrics 130:660-6. 2012
  4. pmc Development and validation of the WEll-being and Satisfaction of CAREgivers of Children with Diabetes Questionnaire (WE-CARE)
    Joseph C Cappelleri
    Pfizer Global Research and Development, Groton, CT, USA
    Health Qual Life Outcomes 6:3. 2008
  5. ncbi request reprint Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, State University of New York at Buffalo, 14222, USA
    J Pediatr Endocrinol Metab 14:267-77. 2001
  6. ncbi request reprint Inhaled insulin: a novel and non-invasive way for insulin administration?
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women and Children s Hospital of Buffalo, Associate Professor of Pediatrics, State University of New York at Buffalo, 219 Bryant Street, Buffalo, New York 14222, USA
    Curr Drug Saf 1:151-8. 2006
  7. ncbi request reprint Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial
    Teresa Quattrin
    The Women and Children s Hospital of Buffalo, School of Medicine and Biochemical Sciences, State University of New York at Buffalo, Buffalo, New York 14222, USA
    Diabetes Care 27:2622-7. 2004
  8. ncbi request reprint Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes
    Teresa Quattrin
    State University of New York at Buffalo, Division of Endocrinology, The Women and Children s Hospital of Buffalo, Kaleida Health, 219 Bryant St, Buffalo, NY 14222, USA
    Expert Opin Pharmacother 5:2597-604. 2004
  9. ncbi request reprint Obese children who are referred to the pediatric endocrinologist: characteristics and outcome
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women s and Children s Hospital of Buffalo, 219 Bryant St, Buffalo, NY 14222, USA
    Pediatrics 115:348-51. 2005
  10. ncbi request reprint Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, New York, USA
    Diabetes Care 20:374-80. 1997

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Treatment outcomes of overweight children and parents in the medical home
    Teresa Quattrin
    Department of Pediatrics, University at Buffalo, Women and Children s Hospital, Buffalo, New York
    Pediatrics 134:290-7. 2014
    ..To test in the primary care setting the short- and long-term efficacy of a behavioral intervention that simultaneously targeted an overweight child and parent versus an information control (IC) targeting weight control only in the child...
  2. pmc Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study
    Lucy Mastrandrea
    Department of Pediatrics, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA
    Diabetes Care 32:1244-9. 2009
    ..To gather preliminary data on the feasibility and efficacy of etanercept therapy to prolong endogenous insulin production in pediatric patients with newly diagnosed type 1 diabetes...
  3. pmc Efficacy of family-based weight control program for preschool children in primary care
    Teresa Quattrin
    Pediatric University at Buffalo, Buffalo, New York, USA
    Pediatrics 130:660-6. 2012
    ..To test the efficacy of an innovative family-based intervention for overweight preschool-aged children and overweight parents conducted in the primary care setting...
  4. pmc Development and validation of the WEll-being and Satisfaction of CAREgivers of Children with Diabetes Questionnaire (WE-CARE)
    Joseph C Cappelleri
    Pfizer Global Research and Development, Groton, CT, USA
    Health Qual Life Outcomes 6:3. 2008
    ....
  5. ncbi request reprint Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, State University of New York at Buffalo, 14222, USA
    J Pediatr Endocrinol Metab 14:267-77. 2001
    ..We present the efficacy and safety data pertinent to the younger subset of participants (11-21 years)...
  6. ncbi request reprint Inhaled insulin: a novel and non-invasive way for insulin administration?
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women and Children s Hospital of Buffalo, Associate Professor of Pediatrics, State University of New York at Buffalo, 219 Bryant Street, Buffalo, New York 14222, USA
    Curr Drug Saf 1:151-8. 2006
    ..In these patients, who had received inhaled insulin for at least 4 years, annualized changes of FEV1 and DLCO were similar in the group treated with inhaled insulin compared to the group treated with sub-cutaneous insulin...
  7. ncbi request reprint Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial
    Teresa Quattrin
    The Women and Children s Hospital of Buffalo, School of Medicine and Biochemical Sciences, State University of New York at Buffalo, Buffalo, New York 14222, USA
    Diabetes Care 27:2622-7. 2004
    ..The aim of this study was to determine whether premeal pulmonary delivery of rapid-acting, dry-powder insulin (Exubera) plus Ultralente could provide glycemic control comparable to a conventional insulin regimen in type 1 diabetes...
  8. ncbi request reprint Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes
    Teresa Quattrin
    State University of New York at Buffalo, Division of Endocrinology, The Women and Children s Hospital of Buffalo, Kaleida Health, 219 Bryant St, Buffalo, NY 14222, USA
    Expert Opin Pharmacother 5:2597-604. 2004
    ..Further studies are needed to clarify the significance of this finding. Inhaled insulin appears to be a non-invasive, well-tolerated and -liked modality of treatment, with potential in both Type 1 and 2 diabetes...
  9. ncbi request reprint Obese children who are referred to the pediatric endocrinologist: characteristics and outcome
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women s and Children s Hospital of Buffalo, 219 Bryant St, Buffalo, NY 14222, USA
    Pediatrics 115:348-51. 2005
    ..The objective of this study was to characterize a population of obese children who were referred to a pediatric endocrinology clinic and to analyze the outcome of the referral...
  10. ncbi request reprint Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, New York, USA
    Diabetes Care 20:374-80. 1997
    ..To examine if dual replacement with insulin and rhIGF-I, recombinant human insulin-like growth factor I (rhIGF-I) may be safe and result in improved metabolic control and reduced insulin usage...
  11. ncbi request reprint Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system
    K Thrailkill
    Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Clin Endocrinol Metab 82:1181-7. 1997
    ....
  12. ncbi request reprint Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group
    K M Thrailkill
    Department of Pediatrics, University of Kentucky, Lexington, USA
    Diabetes Care 22:585-92. 1999
    ..To study the effects of 12 weeks of cotherapy with recombinant human IGF-I (rhIGF-I) and insulin on glycemic control in patients with type 1 diabetes...
  13. ncbi request reprint Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial
    Neil H White
    Department of Pediatrics, Washington University School of Medicine, St Louis, MO 63110, USA
    J Pediatr Endocrinol Metab 21:555-68. 2008
    ..To compare the efficacy and safety of Exubera (EXU) with subcutaneous (SC) insulin in children, ages 6-11 years, with type 1 diabetes mellitus...
  14. ncbi request reprint Clinical evaluation of inhaled insulin
    Lucy D Mastrandrea
    Division of Endocrinology Diabetes, Department of Pediatrics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, The Women s and Children s Hospital, 219 Bryant Street, Buffalo, New York 14222, USA
    Adv Drug Deliv Rev 58:1061-75. 2006
    ..In addition, the efficacy of inhaled insulin in both type 1 and type 2 diabetic populations will be discussed. Finally, the available safety data with respect to the unique pulmonary effects of inhaled insulin will be covered...
  15. pmc Young women with type 1 diabetes have lower bone mineral density that persists over time
    Lucy D Mastrandrea
    Department of Pediatrics, University at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York, USA
    Diabetes Care 31:1729-35. 2008
    ..We here report 2-year follow-up BMD data in this cohort to determine the natural history of BMD in young women with and without diabetes...
  16. ncbi request reprint Detecting overweight children in primary care: do national data reflect the typical urban practice?
    Elena Sutu
    Division of Endocrinology Diabetes, Women and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Fam Pract 55:976-80. 2006
    ..Children seen for a sick-child visit may be at higher risk for overweight; thus, we recommend that height and weight measurements be obtained during these visits...
  17. ncbi request reprint Does low bone mineral density start in post-teenage years in women with type 1 diabetes?
    Emily Y Liu
    The Women and Children s Hospital of Buffalo, Division of Endocrinology Diabetes, Buffalo, New York 14222, USA
    Diabetes Care 26:2365-9. 2003
    ....
  18. ncbi request reprint Fasting glucose is a risk factor for breast cancer: a prospective study
    Paola Muti
    Department of Social and Preventive Medicine, University at Buffalo, State University of New York, Buffalo 14214, USA
    Cancer Epidemiol Biomarkers Prev 11:1361-8. 2002
    ..These results indicate that chronic alteration of glucose metabolism is related to breast cancer development...

Research Grants3

  1. Treating Overweight Youth: A Family Based Approach in Primary Care
    Teresa Quattrin; Fiscal Year: 2009
    ..This study is an important step towards providing pediatricians with effective tools to treat overweight in primary care. ..
  2. Treating Overweight Youth: A Family Based Approach in Primary Care
    Teresa Quattrin; Fiscal Year: 2010
    ..This study is an important step towards providing pediatricians with effective tools to treat overweight in primary care. ..